Abstract:
Engineered non-plant cells that produce a benzylisoquinoline alkaloid product that is a derivative of canadine along a metabolic pathway that converts canadine, or an analog of canadine, to a noscapinoid product are provided. Methods of culturing engineered non-plant cells that produce a noscapinoid product and pharmaceutical compositions are also provided.
Abstract:
DNA and protein compositions useful for both diagnosis and design of therapeutics for treatment of tuberculosis and other mycobacterial infections. More specifically, the present invention relates to DNA and protein compositions which are responsible for the cyclopropanation of mycolic acids in M. tuberculosis and other pathogenic forms of mycobacterium.
Abstract:
Die Erfindung betrifft eine transgene Pflanze der Art Beta vulgaris, in deren Genom eine Nukleinsäure stabil integriert wurde, von der in der Pflanze RNA transkribiert wird, wobei gebildete RNA im Falle eines Befalls der Pflanze mit einem Pilz der Gattung Cercospora von diesem aufgenommen werden kann, so dass die Cercosporin-Biosynthese in dem Pilz derart beeinträchtigt wird, dass der Pilz in seiner biotrophen Wachstumsphase gehemmt wird und die Pflanze im Vergleich zu einer Kontrollpflanze eine gesteigerte Resistenz gegenüber dem Pilz aufweist.
Abstract:
The subject invention provides novel polynucleotides and polypeptides encoding a methyltransferase. The subject invention provides novel plants that express the methyltrasferase disclosed herein and are resistant to auxin-based herbicides. The subject invention also provides transgenic plants have been transformed with one or more other herbicide resistance genes such that the plants are resistant to the application of auxin-based herbicides and one or more other herbicides.
Abstract:
The present invention features improved methods for the enhanced production of pantoate and pantothenate utilizing microorganisms having modified pantothenate biosynthetic enzyme activities and having modified methylenetetrahydrofolate (MTF) biosynthetic enzyme activities. In particular, the invention features methods for enhancing production of desired products by increasing levels of a key intermediate, ketopantoate, by increasing enzymes or substrates that contribute directly or indirectly to its synthesis. Recombinant microorganisms and conditions for culturing same are also featured. Also featured are compositions produced by such microorganisms.
Abstract:
The invention relates to a transgenic plant of the species Beta vulgaris, into the genome of which a nucleic acid was stably integrated. From said nucleic acid RNA is transcribed in the plant, wherein RNA formed in the event of an infestation of the plant with a fungus of the genus Cercospora can be taken up by said RNA so that the Cercosporin biosynthesis in the fungus is impaired in such a manner that biotrophic growth phase of the fungus is inhibited and the plant has an enhanced resistance to the fungus compared with a control plant.
Abstract:
The subject invention provides novel polynucleotides and polypeptides encoding a methyltransferase. The subject invention provides novel plants that express the methyltrasferase disclosed herein and are resistant to auxin-based herbicides. The subject invention also provides transgenic plants that have been transformed with one or more other herbicide resistance genes such that the plants are resistant to the application of auxin-based herbicides and one or more other herbicides.
Abstract:
Novel isonitrile biosynthetic enzymes isnA and isnB which together possess a catalytic activity of converting an amine-containing compound to an isonitrile-containing compound are described. The genes that encode such enzymes, recombinant vectors containing one or both of such genes, a host cell transformed with said vector, methods for the production and isolation of the enzymes of the invention are also described. Methods for the identification of bioactive, isonitrile-containing natural products derived from the biosynthetic activity of the enzymes of the invention, and methods for synthetically producing isonitrile-containing compounds from the isolated enzymes of the invention are also described.
Abstract:
The present invention provides metabolic markers and targets, especially PEMT activity and metabolic markers and components associated therewith useful for diagnosing and treating various disease conditions.
Abstract:
Novel isonitrile biosynthetic enzymes isnA and isnB which together possess a catalytic activity of converting an amine-containing compound to an isonitrile-containing compound are described. The genes that encode such enzymes, recombinant vectors containing one or both of such genes, a host cell transformed with said vector, methods for the production and isolation of the enzymes of the invention are also described. Methods for the identification of bioactive, isonitrile-containing natural products derived from the biosynthetic activity of the enzymes of the invention, and methods for synthetically producing isonitrile-containing compounds from the isolated enzymes of the invention are also described.